InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.495

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$171 Change of Director's Interest Notice - BW 31 Mar 2023 2:45PM $1.060 $0.495 fallen by 53.30%
$171 Change of Director's Interest Notice - PM 31 Mar 2023 2:43PM $1.060 $0.495 fallen by 53.30%
$171 Change of Director's Interest Notice - JD 31 Mar 2023 2:41PM $1.060 $0.495 fallen by 53.30%
$171 Notification regarding unquoted securities - ARX 31 Mar 2023 2:35PM $1.060 $0.495 fallen by 53.30%
$171 Aroa awarded agreement with Premier Inc 6 Mar 2023 8:50AM $1.100 $0.495 fallen by 55%
$171 Application for quotation of securities - ARX 3 Feb 2023 2:51PM $1.145 $0.495 fallen by 56.77%
$171 Section 708A Notice 3 Feb 2023 2:49PM $1.140 $0.495 fallen by 56.58%
$171 Investor Presentation 31 Jan 2023 10:49AM $1.240 $0.495 fallen by 60.08%
$171 December 2022 Quarterly Report and Appendix 4C 31 Jan 2023 9:12AM $1.235 $0.495 fallen by 59.92%
$171 Notification of Quarterly Results Webinar 24 Jan 2023 10:02AM $1.210 $0.495 fallen by 59.09%
$171 Notification of cessation of securities - ARX 12 Jan 2023 2:21PM $1.160 $0.495 fallen by 57.33%
$171 Notification of cessation of securities - ARX 11 Jan 2023 10:13AM $1.175 $0.495 fallen by 57.87%
$171 Notification regarding unquoted securities - ARX 5 Jan 2023 10:32AM $1.130 $0.495 fallen by 56.19%
$171 Change of Director's Interest Notice - JD 16 Dec 2022 10:20AM $1.055 $0.495 fallen by 53.08%
$171 Notification regarding unquoted securities - ARX 16 Dec 2022 10:17AM $1.055 $0.495 fallen by 53.08%
$171 Section 708A Notice 16 Dec 2022 10:16AM $1.055 $0.495 fallen by 53.08%
$171 Application for quotation of securities - ARX 16 Dec 2022 10:15AM $1.055 $0.495 fallen by 53.08%
$171 Notification regarding unquoted securities - ARX 12 Dec 2022 10:57AM $1.080 $0.495 fallen by 54.17%
$171 Aroa Half Year Results Presentation 29 Nov 2022 10:56AM $1.075 $0.495 fallen by 53.95%
$171 Aroa Biosurgery Half Yearly Results H1 FY23 29 Nov 2022 9:14AM $1.055 $0.495 fallen by 53.08%
$171 Appendix 4D and Half Year Report 29 Nov 2022 9:09AM $1.055 $0.495 fallen by 53.08%
$171 Notification regarding unquoted securities - ARX 28 Nov 2022 2:23PM $1.070 $0.495 fallen by 53.74%
$171 Appendix 3G 28 Nov 2022 2:23PM $1.070 $0.495 fallen by 53.74%
$171 Notification of Half Year Results Webinar 23 Nov 2022 9:34AM $1.050 $0.495 fallen by 52.86%
$171 Initial Director's Interest Notice - CM 8 Nov 2022 1:52PM $0.850 $0.495 fallen by 41.76%

201 - 225 of 777 results

Page 9 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.